25 related articles for article (PubMed ID: 10589772)
1. Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.
Kannapadi NV; Shah PP; Mathios D; Jackson CM
Front Oncol; 2022; 12():892004. PubMed ID: 35712492
[TBL] [Abstract][Full Text] [Related]
2. Checkpoint blockade in recurrent meningiomas: Lessons for future management.
Pant A; Lim M
Neuro Oncol; 2022 Jan; 24(1):114-115. PubMed ID: 34626195
[No Abstract] [Full Text] [Related]
3. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
[TBL] [Abstract][Full Text] [Related]
4. Serological detection of cutaneous T-cell lymphoma-associated antigens.
Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
[TBL] [Abstract][Full Text] [Related]
5. Genetic landscape of meningioma.
Yuzawa S; Nishihara H; Tanaka S
Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
[TBL] [Abstract][Full Text] [Related]
6. Novel tankyrase-related gene detected with meningioma-specific sera.
Monz D; Munnia A; Comtesse N; Fischer U; Steudel WI; Feiden W; Glass B; Meese EU
Clin Cancer Res; 2001 Jan; 7(1):113-9. PubMed ID: 11205898
[TBL] [Abstract][Full Text] [Related]
7. MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Comtesse N; Niedermayer I; Glass B; Heckel D; Maldener E; Nastainczyk W; Feiden W; Meese E
Oncogene; 2002 Jan; 21(2):239-47. PubMed ID: 11803467
[TBL] [Abstract][Full Text] [Related]
8. cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients.
Heckel D; Brass N; Fischer U; Blin N; Steudel I; Türeci O; Fackler O; Zang KD; Meese E
Hum Mol Genet; 1997 Nov; 6(12):2031-41. PubMed ID: 9356211
[TBL] [Abstract][Full Text] [Related]
9. Novel immunogenic antigen homologous to hyaluronidase in meningioma.
Heckel D; Comtesse N; Brass N; Blin N; Zang KD; Meese E
Hum Mol Genet; 1998 Nov; 7(12):1859-72. PubMed ID: 9811929
[TBL] [Abstract][Full Text] [Related]
10. Deletions on chromosome 22 in sporadic meningioma.
Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
[TBL] [Abstract][Full Text] [Related]
11. Five novel immunogenic antigens in meningioma: cloning, expression analysis, and chromosomal mapping.
Comtesse N; Heckel D; Rácz A; Brass N; Glass B; Meese E
Clin Cancer Res; 1999 Nov; 5(11):3560-8. PubMed ID: 10589772
[TBL] [Abstract][Full Text] [Related]
12. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
Pergolizzi RG; Erster SH
Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
